Therefore, to identify trajectories of NT-proBNP changing over time, we applied GBTM to repeated measurements of NT-proBNP levels in peripheral blood within 1 year from baseline in a CTD-PAH cohort, and we subsequently evaluated the association between NT-proBNP trajectories and prognosis. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.